• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Renal denervation as an option for the management of hypertension

    2014-04-18 11:58:34GeorginaRadhiniSantiapillaiAlbertFerro
    THE JOURNAL OF BIOMEDICAL RESEARCH 2014年1期

    Georgina Radhini Santiapillai, Albert Ferro

    Department of Clinical Pharmacology, Cardiovascular Division, British Heart Foundation Centre of Research Excellence, King's College London, London, UK.

    Renal denervation as an option for the management of hypertension

    Georgina Radhini Santiapillai, Albert Ferro

    Department of Clinical Pharmacology, Cardiovascular Division, British Heart Foundation Centre of Research Excellence, King's College London, London, UK.

    Hypertension is a multifactorial condition which makes the development of treatment approaches difficult. The vast majority of patients are treated with lifestyle measures either alone or in combination with antihypertensive drugs, and this approach is largely successful in controlling blood pressure. However, for a subgroup of patients, control of blood pressure remains resistant to this approach and therefore the development of new strategies is imperative. The sympathetic nervous system has been known to be implicated in hypertension for many decades, and evidence from studies in the past has revealed the benefit of reducing sympathetic nerve activity in the control of blood pressure albeit with severe side effects. Recent technological advances have allowed for specific targeting of the renal sympathetic nerves by catheter ablation. The Symplicity HTN-1 and HTN-2 trials have provided strong evidence for renal denervation giving rise to considerable blood pressure reductions in treatment-resistant hypertensives and, due to the high incidence of hypertension worldwide, this carries the promise of further reducing the global burden of hypertension and its attendant complications. Here we review the evidence for renal denervation in the management of hypertension.

    hypertension, renal denervation, blood pressure

    INTRODUCTION

    Hypertension is a chronic condition which greatly increases the risk of developing cardiovascular disease, the leading cause of death worldwide as classified by the World Health Organisation (WHO)[1]. It is estimated that over a quarter of the world's adult population is hypertensive, and therefore therapeutic approaches that offer good control of blood pressure are of prime importance on a global scale[2].

    Hypertension is a major modifiable risk factor for cardiovascular disease[3]. It has been shown that a systolic blood pressure (SBP) increase of over 20 mmHg doubles the cardiovascular mortality risk, and that even small reductions in blood pressure significantly reduce the risk of cardiovascular events such as stroke[4,5]. First-line treatment involves advice about lifestyle changes, with subsequent pharmacological strategies being implemented if hypertension persists despite lifestyle measures. However, successful treatment of hypertension can be difficult to achieve in a significant minority of patients, who may fail to respond to antihypertensive medications of any class either alone or in combination.

    Resistant hypertension is defined as blood pressure above 140/90 mmHg in spite of the use of three or more antihypertensive agents, including a diuretic[6,7]. Essential hypertension has a multi-factorial aetiology which makes development of new therapeutic strategies a necessity, one novel approach being specific targeting of the sympathetic nervous system.

    Sympathetic nerves innervate, amongst others, organs involved in cardiovascular regulation; of particular relevance to hypertension is sympathetic innervations of the kidney[8]. It is well established that sympathetic nerves are involved in the development and maintenance of hypertension through increased sympathetic activity to the kidneys. Renal efferent and afferent nerves are situated inside the renal artery wall and perivascular soft tissue respectively[9]. Efferent nerve stimulation to the kidneys acts to increase blood pressure firstly by increased sodium reabsorption from the tubules, and secondly by increased renin secretion thereby activating the renin-angiotensin-aldosterone axis[10]. Chronic activation of renal afferents is found in certain disease states such as renal failure, which results in the kidneys being a source of sympathetic drive in the hypertension associated with renal failure (Fig. 1).

    The involvement of sympathetic nerve activation in the hypertensive state makes these nerves a rational therapeutic target. Before the advent of antihypertensive drugs, non-specific surgical methods to decrease sympathetic nerve activity were used as early as the 1920s to reduce blood pressure in patients with severe hypertension[11]. These attempts were extremely successful at lowering blood pressure in treated patients, however, the lack of specificity with such extensive denervation meant that there was high periprocedural morbidity and mortality. Selective renal sympathetic denervation, therefore, represents a more attractive therapeutic approach.

    Recent developments in device-based approaches to hypertension targeting the renal sympathetic system include a novel percutaneous catheter-based treatment. Here, radiofrequency energy is used to denervate sympathetic nerve fibres within the artery. The aim of this treatment is to selectively disrupt sympathetic nerve fibres without causing adverse effects in other organ systems[8]. Evidence from the Symplicity HTN-1 and HTN-2 trials in recent years has provided promising results which demonstrate significant and large decreases in blood pressure in patients withdrug-resistant hypertension. At present, however, there is insufficient evidence of long term benefit and the procedure has only been trialled in relatively small numbers of patients[12].

    Fig. 1 Renal afferent and efferent signalling from and to the kidney.

    PROCEDURE

    A catheter-based approach to renal sympathetic denervation has been developed. Early approaches involving the sympathetic nervous system in hypertension, as mentioned before, have highlighted the need for targeting the renal sympathetic nerves more specifically. From the radical sympathectomies and splanchnicectomies of the 1920s, to the marginally more successful targeted removal of renal sympathetic ganglia by Grimson et al.[13], there have been several attempts at attenuating sympathetic nerve activity in the context of blood pressure[8]. These measures have demonstrated the effectiveness of therapies that reduce sympathetic nerve activity on long-term blood pressure control, but equally highlight the need for more specific methods without the side effects of previous approaches.

    A minimally invasive, endovascular catheterbased procedure aims to disrupt neurogenic reflexes involved in the control of blood pressure using radiofrequency (RF) energy[12]. The rationale for this targeted treatment is based firstly on the fact that since the kidneys are retroperitoneal organs, direct access to the nerves is difficult, secondly, the fact that the renal efferent and afferent nerves are in close proximity to the renal artery wall, allowing for greater susceptibility to RF energy if approached by the endovascular route. In a human post-mortem histological study, Atherton et al.[9]used sections from human renal arteries and measured the distance of nerves from the lumen-intima interface. It was found that over 90% of renal sympathetic nerves resided within 2 mm of the renal artery lumen; considering the RF penetration depth of a cardiac ablation catheter is up to 9.5 mm[14], a catheter-based RF approach in specifically targeting renal sympathetic nerves is likely to be feasible.

    Before introducing the catheter, angiography is used to determine renal anatomic eligibility for the procedure, to exclude any renal artery stenosis or other abnormality of renal artery anatomy. The procedure is carried out under local anesthesia, whereby the catheter is inserted through the femoral artery and guided into each renal artery under fluoroscopic control. A generator delivers low-power RF ablations within each ‘renal artery at 4-6 points along its length, in a spiral pattern’[12]. Ablations last two minutes each and are spaced both longitudinally and rotationally along the course of the renal artery (Fig. 2). A predetermined algorithm allows for automatic generation of RF energy and careful monitoring throughout the procedure of temperature and impedance.

    PRECLINICAL EVIDENCE

    Preclinical experiments that have used renal denervation therapeutically have used a variety of animal models in which to assess renal sympathetic nerve contribution to systemic organ function. One study by Kassab et al. assessed the effect of renal sympathetic nerve ablation on blood pressure using a canine model of obesity-induced hypertension[15]. Obesity is commonly observed in hypertensive patients and therefore is a good model to study the effect of a novel blood pressure-lowering strategy.

    In this study, two groups were evaluated: a control group and a bilaterally renal-denervated group. Both groups were, after a control period, fed a highfat diet, which resulted in a rise in body weight in the two groups by 50%. The study found that, with the high-fat diet, there was a significant increase in blood pressure in the control dogs (from 95 ± 2 to 109 ± 4 mmHg) but no significant change in blood pressure in the denervated dogs (87 ± 3 to 90 ± 4 mmHg). Another endpoint of this study looked at the effect of renal denervation on sodium retention, which is thought to be increased with efferent nerve stimulation. In the denervated dogs, cumulative sodium retention was approximately 50% less than in the controls (control: 445 ± 85 mmol, denervated: 252 ± 47 mmol). The findings from this study support the theory that renal sympathetic activity is involved in mediating hypertension and sodium retention associated with obesity. This is concordant with other renal denervation preclinical studies, that have similarly shown attenuation of hypertension in other animal models[16].

    Of relevance to the catheter-based approach, a study by Rippy et al.[17]used a healthy swine model. Here they tested the vascular safety and healing response of RF ablations given via the Symplicity Catheter System. Angiography and histological analyses were carried out before the procedure and at 6 months post-ablation, assessing for any perfusion defects and vascular damage respectively. The study found that catheter-based denervation could selectively ablate the renal nerves without causing any clinically significant damage to the renal artery wall or other renal pathology, suggesting the catheter system to have a good safety profile and paving the way for proof-of-principle and randomized controlled trials in humans.

    Fig. 2 Schematic representation of catheter placement and ablation sites.

    CLINICAL TRIALS

    Proof-of-principle study

    In recent years, several clinical trials have been published that provide good evidence for renal denervation having an antihypertensive effect. The first proof-of-principle cohort study was carried out by Krum and colleagues[18]with the aim of evaluating the safety and blood pressure-lowering efficacy of specific renal nerve denervation. In the Symplicity HTN-1 study, 45 patients with treatment-resistant hypertension underwent renal sympathetic nerve ablation using a catheter-based approach (Symplicity by Ardian Inc. Palo Alto, CA, USA). Treatment-resistant hypertension was defined as baseline SBP≥160 mmHg despite use of three or more antihypertensive drugs. Patients had a mean age of 58 ± 9 years, average blood pressure of 177/101 ± 20/15 mmHg and were using an average of 4.7 ± 1.5 antihypertensive medications. The procedure itself was noted to cause visceral abdominal pain that was present only during the procedure on application of RF energy; this was managed with intravenous narcotics and sedatives. The median procedure time was 38 min.

    Short term follow-up angiography 14-30 days after the procedure and magnetic resonance (MR) angiography at 6 months showed a good vascular safety profile with no adverse clinical events related to the treatment, nor was any alteration in renal function noted. There was a significant decrease in blood pressure (systolic: 20-25 mmHg; diastolic: 10-15 mmHg) which persisted throughout the one year follow-up period (Table 1).

    In agreement with the reductions in blood pressure seen after treatment, a decrease in efferent sympathetic activity was shown in terms of noradrenaline release from the kidneys (measured as spillover of noradrenaline into the circulation). In the subgroup of 10 patients who underwent this test, there was a mean decrease in noradrenaline spillover of 47% (95% CI, 28-65%). This demonstrates the efficacy of the catheter-based device in achieving efferent sympathetic denervation[18].

    Independent review of angiograms and serious adverse events reduced the possibility of bias in data analysis. However, as the study was non-blinded and did not have a control group, due to the study being proof-of-concept, a placebo effect may have played a part. A serious limitation to this study is the selection of the trial population. Eligible patients were those who had resistant hypertension; however, resistant hypertension is a multifactorial condition which encompasses several causes including white coat hypertension, secondary hypertension and poor adherence to medication[6]. These are factors that were not evaluated and accounted for within the study. In addition, at the 9- and 12- month follow-up points, there was a considerable attrition of patients available for followup, as shown in Table 1. Overall, however, the studyprovides promising support for the effectiveness of renal sympathetic ablation as a strategy in the management of resistant hypertension.

    Table 1 Effect of renal denervation on blood pressure as a function of time

    Expanded cohort study

    Two year follow-up evidence from the original study reaffirmed the notion that catheter-based renal denervation contributes to a long-term substantial decrease in blood pressure[19]. The expanded cohort study assessed the durability of the blood pressurelowering effect, of importance due to sympathetic efferents having previously been shown to regrow after nerve injury[20]. In this expanded cohort study, 153 patients with the same inclusion criteria were treated by the same approach used in the initial cohort study[19]. It was found that the initial blood pressure reduction seen post-procedure in the initial study continued out to 24 months on follow-up. Over 90% of patients had an office blood pressure reduction of over 10 mmHg, averaging 32/14 mmHg at 24 months. This is of relevance when considering that the patient population was previously unresponsive to three or more hypertensive medications, further supporting the findings from the initial trial.

    Symplicity HTN-2

    The Symplicity HTN-2 randomized control trial[21]built upon the impressive findings from the proof-ofprinciple study. This study sought to further clarify the effectiveness and safety of catheter-based treatment of resistant hypertension. One hundred and six patients with treatment-resistant hypertension were enrolled. Similar inclusion criteria to the initial cohort study were used, with the additional inclusion of patients with type 2 diabetes who had a baseline SBP of≥ 150 mmHg and fulfilled the additional criteria specified. Patients were then randomized to renal sympathetic denervation (n = 52) or control (n = 54) groups and followed up over a period of 6 months.

    At 6 months post-procedure, office blood pressure measurements in the renal denervation group were decreased significantly, by 32/12 mmHg (SD 23/11, baseline mean blood pressure 178/96 mmHg; P < 0.0001), in comparison to no significant change in blood pressure observed in the control group. The difference in the primary endpoint of seated office blood pressure between the groups at 6 months was significant at 33/11 mmHg (P < 0.0001 for both SBP and DBP). Additionally, in a subgroup of patients where home and ambulatory blood pressure were measured, similar findings were observed. From baseline values, the renal denervation group (n = 20) had a decrease from baseline values for mean systolic and diastolic blood pressure of 11/7 mmHg (SD 15/11; P = 0.006 for SBP and P = 0.014 for DBP change) whereas there was no significant change in the control group (n = 25)[21]. Furthermore, no adverse clinical events related to the procedure were seen, which substantiates earlier trial evidence about the good safety profile of this technique.

    Since this was a randomized controlled trial, this largely answers the potential criticisms above of a possible placebo effect and selection bias that could affect the validity of the results. Having said that, the control group did not undergo a sham operation; therefore, the trial was not double-blinded, so that some possibility of bias remains. Currently, a multicentre, double-blinded, randomized controlled trial (Symplicity HTN-3) is ongoing, evaluating the procedure in a larger group of patients.

    The results of the Symplicity HTN-2 study provide strong evidence to support previous findings that renal denervation is a suitable and effective option in the management of treatment-resistant essential hypertension. The data are encouraging based on good efficacy in blood pressure control and good safety profile.

    Future Prospects

    Renal denervation by catheter ablation has been shown to have promising results in the Symplicity clinical trials. However, the exact pathophysiological mechanism by which denervation causes blood pressure reduction is yet to be elucidated precisely. Radiotracer dilution methods measuring noradrenaline sp-illover, as used in the proof-of-principle study above, have demonstrated reduced nordadrenaline spillover post-renal denervation, suggesting that the procedure may lower blood pressure by reducing efferent renal sympathetic nerve stimulation[8]. But whether a decrease in adrenergic activity occurs before blood pressure reduction remains to be determined.

    Sympathetic reinnervation is important to consider in assessing the long-term durability of renal nerve denervation and its blood pressure-lowering effects. There is a possibility that sympathetic nerves can regrow after damage. The evidence for good long-term efficacy in the two year follow-up study suggests that, despite the possibility of regrowth and reinnervation, this appears not to affect the blood pressure-lowering effect of the procedure[19]. However, it would be useful to further clarify whether sympathetic reinnervation of the kidney occurs and whether this has an effect on blood pressure control[22]. This requires a longer follow-up period and an increased understanding of the process of reinnervation in the human kidney.

    Importantly, clinical trials assessing renal denervation have been restricted to a specific group of patients with treatment-resistant essential hypertension. The clinical studies thus far have shown good efficacy and safety in these patients, but to further investigate the therapeutic benefit of renal denervation other subgroups of hypertensives need to be evaluated. These could include those that have milder forms of essential hypertension and in patients that have hypertension secondary to disease states such as renal impairment; in the future, it may be useful to examine whether renal denervation is appropriate in the earlier stages of hypertension as a preventative measure[23].

    An additional consideration is that renal denervation has been examined thus far using RF catheter-based ablation. Other methods for achieving renal denervation using methods such as ultrasound, microwaves, lasers and robotic surgery may be useful to trial also.

    CONCLUSION

    Rrenal denervation is a potentially useful treatment modality in patients whose hypertension is refractory to conventional hypertension therapies. Targeting sympathetic nerves to reduce blood pressure is an old concept that has been brought to the fore of novel antihypertensive therapies with the development of sophisticated devices that have specificity in their application. The promising results from catheter-based renal sympathetic denervation have offered new prospects, specifically in the treatment of resistant essential hypertension. Both the HTN-1 and HTN-2 studies demonstrated the good safety profile and efficacy in reducing blood pressure using catheter nerve ablation. The UK National Institute for Health and Clinical Excellence has recently published guidelines for its use in suitably chosen patients with resistant hypertension[12].

    Catheter-based treatment is still in the early stages of clinical research, and larger and longer-term follow-up trials will be needed to properly assess the durability of blood pressure reduction as well as longterm safety.

    [1] World Health Organisation. The top 10 causes of death. 2011; Available at: http://www.who.int/mediacentre/ factsheets/fs310/en/index.html. (accessed 12/05, 2012).

    [2] Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-23.

    [3] Poulter N. Global risk of cardiovascular disease. Heart 2003; 89(S2): ii2-ii5.

    [4] Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358: 1682-86.

    [5] Mancia G. Blood pressure reduction and cardiovascular outcomes: past, present, and future. Am J Cardiol 2007; 100 (S): 3J-9J.

    [6] Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008; 117: e510-26.

    [7] Sarafidis PA, Bakris GL. Resistant hypertension: an overview of evaluation and treatment. J Am Coll Cardiol 2008; 52: 1749-57.

    [8] Schlaich MP, Krum H, Sobotka PA, Esler MD. Renal denervation and hypertension. Am J Hypertens 2011; 24: 635-42.

    [9] Atherton DS, Deep NL, Mendelsohn FO. Micro-anatomy of the renal sympathetic nervous system: a human postmortem histologic study. Clin Anat 2012; 25: 628-33.

    [10] DiBona GF. Neural control of the kidney: past, present, and future. Hypertension 2003; 41: 621-4.

    [11] Morrissey DM, Brookes VS, Cooke WT. Sympathectomy in the treatment of hypertension; review of 122 cases. Lancet 1953; 1: 403-8.

    [12] National Institute for Health and Clinical Excellence. Percutaneous transluminal radiofrequency sympathetic denervation of the renal artery for resistant hypertension. 2012; Available at: http://guidance.nice.org.uk/ipg418. (accessed 11/19, 2012).

    [13] Grimson KS. Total Thoracic and partial to total lumbar sympathectomy and celiac ganglionectomy in the treatment of hypertension. Ann Surg 1941; 114: 753-75.

    [14] Holmes D, Fish JM, Byrd IA, Dando JD, Fowler SJ,Cao H, et al. Contact sensing provides a highly accurate means to titrate radiofrequency ablation lesion depth. J Cardiovasc Electrophysiol 2011; 22: 684-90.

    [15] Kassab S, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP. Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension 1995; 25: 893-7.

    [16] Ye S, Zhong H, Yanamadala V, Campese VM. Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity. Am J Hypertens 2002; 15: 717-24.

    [17] Rippy MK, Zarins D, Barman NC, Wu A, Duncan KL, Zarins CK. Catheter-based renal sympathetic denervation: chronic preclinical evidence for renal artery safety. Clin Res Cardiol 2011; 100: 1095-1101.

    [18] Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009; 373: 1275-81.

    [19] Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 2011; 57: 911-7.

    [20] Kaye DM, Esler M, Kingwell B, McPherson G, Esmore D, Jennings G. Functional and neurochemical evidence for partial cardiac sympathetic reinnervation after cardiac transplantation in humans. Circulation 1993; 88: 1110-8.

    [21] Symplicity HTN-2 Investigators, Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, et al. Renal sympathetic denervation in patients with treatmentresistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010; 376: 1903-9.

    [22] Grassi G, Mancia G. New therapeutic approaches for resistant hypertension. J Nephrol 2012; 25: 276-81.

    [23] Doumas M, Douma S. Renal sympathetic denervation: the jury is still out. Lancet 2010; 376: 1878-80.

    Received 23 March 2013, Revised 16 April 2013, Accepted 02 May 2013, Epub 02 June 2013

    The authors reported no conflict of interests.

    10.7555/JBR.27.20130036

    午夜视频精品福利| 精品一区二区三区视频在线观看免费 | 国产av又大| 亚洲精华国产精华精| 99国产精品一区二区蜜桃av | 欧美+亚洲+日韩+国产| 久久国产亚洲av麻豆专区| av片东京热男人的天堂| 国产精品成人在线| 久久亚洲真实| 人成视频在线观看免费观看| 国产伦人伦偷精品视频| 久久久久精品人妻al黑| 91麻豆精品激情在线观看国产 | 熟女少妇亚洲综合色aaa.| 国产麻豆69| 久久免费观看电影| 母亲3免费完整高清在线观看| 欧美日韩中文字幕国产精品一区二区三区 | 欧美性长视频在线观看| 成人永久免费在线观看视频 | 男女之事视频高清在线观看| 亚洲一码二码三码区别大吗| 久久精品国产亚洲av高清一级| 欧美激情高清一区二区三区| 国产成人影院久久av| 欧美精品一区二区免费开放| 如日韩欧美国产精品一区二区三区| 国产黄色免费在线视频| 狠狠狠狠99中文字幕| 丝袜美腿诱惑在线| 国产精品九九99| 欧美日韩中文字幕国产精品一区二区三区 | 嫩草影视91久久| 国产日韩欧美在线精品| 天天影视国产精品| 亚洲精品久久成人aⅴ小说| 亚洲熟妇熟女久久| 国产成人av教育| 99精品在免费线老司机午夜| 亚洲伊人色综图| 国产亚洲欧美在线一区二区| 视频区图区小说| 丁香六月欧美| 男人舔女人的私密视频| 欧美老熟妇乱子伦牲交| 久久中文字幕人妻熟女| 黑人巨大精品欧美一区二区蜜桃| av天堂在线播放| www.999成人在线观看| 久久久久久久久久久久大奶| 人人妻人人澡人人看| 在线播放国产精品三级| 欧美 亚洲 国产 日韩一| 国产无遮挡羞羞视频在线观看| 午夜免费成人在线视频| 深夜精品福利| 亚洲av日韩在线播放| 在线av久久热| 亚洲精品久久午夜乱码| 九色亚洲精品在线播放| 天天躁狠狠躁夜夜躁狠狠躁| 国产精品一区二区在线观看99| 久久精品亚洲av国产电影网| 精品一区二区三区四区五区乱码| 亚洲欧洲精品一区二区精品久久久| 精品久久久精品久久久| 黑人巨大精品欧美一区二区mp4| 涩涩av久久男人的天堂| 99精品欧美一区二区三区四区| 99精国产麻豆久久婷婷| 欧美日韩成人在线一区二区| 免费不卡黄色视频| 制服人妻中文乱码| 亚洲成人手机| 又黄又粗又硬又大视频| 老司机靠b影院| av在线播放免费不卡| 欧美黄色片欧美黄色片| 深夜精品福利| 黄色视频,在线免费观看| 少妇裸体淫交视频免费看高清 | 日韩大码丰满熟妇| 精品国产乱码久久久久久小说| 午夜成年电影在线免费观看| 丰满少妇做爰视频| 国产精品久久久久久精品电影小说| 亚洲午夜精品一区,二区,三区| 成人特级黄色片久久久久久久 | 久久中文字幕人妻熟女| 日韩大片免费观看网站| 亚洲欧美精品综合一区二区三区| 十八禁网站网址无遮挡| 操美女的视频在线观看| 一边摸一边抽搐一进一出视频| 一区二区日韩欧美中文字幕| 亚洲天堂av无毛| 国产精品电影一区二区三区 | 日韩熟女老妇一区二区性免费视频| 99精国产麻豆久久婷婷| 久久久国产一区二区| 黄色成人免费大全| 亚洲精品美女久久av网站| 最黄视频免费看| 亚洲av成人一区二区三| 在线观看免费视频网站a站| 久久中文字幕人妻熟女| bbb黄色大片| 啦啦啦视频在线资源免费观看| 免费在线观看视频国产中文字幕亚洲| 免费少妇av软件| 狠狠婷婷综合久久久久久88av| 老司机福利观看| 97人妻天天添夜夜摸| 他把我摸到了高潮在线观看 | 女人高潮潮喷娇喘18禁视频| 久久免费观看电影| 国产日韩一区二区三区精品不卡| 国产欧美日韩一区二区三区在线| 最近最新中文字幕大全免费视频| 夫妻午夜视频| 天天躁夜夜躁狠狠躁躁| 欧美在线一区亚洲| 成人影院久久| 国产欧美日韩一区二区三区在线| 国产成人精品久久二区二区91| 免费av中文字幕在线| 精品一区二区三区视频在线观看免费 | 热re99久久国产66热| 国产男靠女视频免费网站| 亚洲av日韩在线播放| 男女高潮啪啪啪动态图| 久久久久久久国产电影| 国产成人精品无人区| 制服人妻中文乱码| 亚洲少妇的诱惑av| a在线观看视频网站| 窝窝影院91人妻| 十八禁高潮呻吟视频| 51午夜福利影视在线观看| 国产激情久久老熟女| 欧美成人午夜精品| 老司机影院毛片| 欧美一级毛片孕妇| 黑人巨大精品欧美一区二区mp4| 99在线人妻在线中文字幕 | 香蕉久久夜色| 人妻一区二区av| 亚洲人成电影免费在线| 色老头精品视频在线观看| av视频免费观看在线观看| 日本av免费视频播放| 午夜91福利影院| 久热这里只有精品99| 成人手机av| 精品高清国产在线一区| 久久天堂一区二区三区四区| e午夜精品久久久久久久| 黄色视频在线播放观看不卡| 美女高潮到喷水免费观看| 99热网站在线观看| 黑人巨大精品欧美一区二区mp4| 欧美激情极品国产一区二区三区| 大码成人一级视频| 妹子高潮喷水视频| 男女之事视频高清在线观看| 在线播放国产精品三级| 精品亚洲成国产av| 国产精品成人在线| 国产成+人综合+亚洲专区| 久久亚洲精品不卡| 人人妻人人澡人人看| 色老头精品视频在线观看| 国产精品二区激情视频| 黄色片一级片一级黄色片| av不卡在线播放| 久久国产精品男人的天堂亚洲| 久久性视频一级片| 欧美国产精品va在线观看不卡| 亚洲第一青青草原| 久久久久视频综合| 成年版毛片免费区| 一个人免费在线观看的高清视频| 欧美久久黑人一区二区| 午夜福利欧美成人| 菩萨蛮人人尽说江南好唐韦庄| 水蜜桃什么品种好| 国产精品av久久久久免费| √禁漫天堂资源中文www| 老汉色∧v一级毛片| 叶爱在线成人免费视频播放| 成人影院久久| 日本五十路高清| av超薄肉色丝袜交足视频| 精品国产乱子伦一区二区三区| 亚洲成人免费av在线播放| 国产精品久久久久久人妻精品电影 | 91老司机精品| 国产精品免费视频内射| a级片在线免费高清观看视频| 欧美亚洲 丝袜 人妻 在线| 国产高清国产精品国产三级| 国产亚洲av高清不卡| 一本一本久久a久久精品综合妖精| 亚洲人成伊人成综合网2020| 亚洲专区国产一区二区| 亚洲欧美一区二区三区黑人| 国产1区2区3区精品| 国产真人三级小视频在线观看| 国产欧美日韩一区二区精品| 国产精品98久久久久久宅男小说| 国产免费av片在线观看野外av| 叶爱在线成人免费视频播放| 精品亚洲乱码少妇综合久久| 欧美老熟妇乱子伦牲交| 亚洲av欧美aⅴ国产| 国产亚洲欧美精品永久| 曰老女人黄片| 无遮挡黄片免费观看| 国产精品av久久久久免费| 亚洲熟女精品中文字幕| 9色porny在线观看| 久久国产精品男人的天堂亚洲| 亚洲熟女精品中文字幕| 岛国在线观看网站| 久久中文字幕一级| 日日爽夜夜爽网站| 亚洲av美国av| 国产亚洲欧美精品永久| 涩涩av久久男人的天堂| 69精品国产乱码久久久| 国产精品1区2区在线观看. | 久久狼人影院| 久久香蕉激情| 精品国产超薄肉色丝袜足j| 91av网站免费观看| 日日摸夜夜添夜夜添小说| av欧美777| 极品人妻少妇av视频| 天堂俺去俺来也www色官网| 中文字幕人妻丝袜制服| 真人做人爱边吃奶动态| 不卡av一区二区三区| av欧美777| 欧美日韩成人在线一区二区| 夜夜骑夜夜射夜夜干| 一本一本久久a久久精品综合妖精| 777米奇影视久久| 国产高清视频在线播放一区| 十八禁人妻一区二区| 久久精品国产综合久久久| 少妇精品久久久久久久| 国产一区二区三区在线臀色熟女 | 亚洲国产av影院在线观看| 日韩中文字幕欧美一区二区| 亚洲国产欧美一区二区综合| av不卡在线播放| 性高湖久久久久久久久免费观看| 淫妇啪啪啪对白视频| 男女无遮挡免费网站观看| 18禁黄网站禁片午夜丰满| 国产精品亚洲一级av第二区| a级毛片在线看网站| 99久久99久久久精品蜜桃| 亚洲成av片中文字幕在线观看| 国产男女内射视频| 国产一区有黄有色的免费视频| 欧美日韩视频精品一区| 国产精品亚洲一级av第二区| 亚洲精华国产精华精| 欧美乱码精品一区二区三区| 国产精品.久久久| 久久ye,这里只有精品| 国产xxxxx性猛交| 国产成人一区二区三区免费视频网站| 纯流量卡能插随身wifi吗| 亚洲一区二区三区欧美精品| 欧美激情久久久久久爽电影 | 亚洲一区中文字幕在线| 国产男女超爽视频在线观看| 啦啦啦视频在线资源免费观看| 亚洲第一青青草原| 欧美精品av麻豆av| 亚洲精品久久成人aⅴ小说| 久久久久久亚洲精品国产蜜桃av| 老汉色∧v一级毛片| 亚洲精品自拍成人| 国产精品99久久99久久久不卡| 久久中文字幕人妻熟女| 国产成人精品久久二区二区免费| 亚洲av日韩精品久久久久久密| 成人18禁高潮啪啪吃奶动态图| 巨乳人妻的诱惑在线观看| 一区二区av电影网| 久久久久久久大尺度免费视频| 超色免费av| 久久久久网色| 在线看a的网站| 91九色精品人成在线观看| 十八禁网站免费在线| 伦理电影免费视频| 久久久欧美国产精品| 777米奇影视久久| 免费看a级黄色片| 免费看十八禁软件| 亚洲精品成人av观看孕妇| 国产福利在线免费观看视频| 一本大道久久a久久精品| 91成年电影在线观看| 啦啦啦中文免费视频观看日本| 黄片小视频在线播放| 国产男女内射视频| 亚洲精品久久成人aⅴ小说| 少妇的丰满在线观看| 伊人久久大香线蕉亚洲五| 中文欧美无线码| 在线观看免费视频日本深夜| 这个男人来自地球电影免费观看| 9热在线视频观看99| 亚洲av第一区精品v没综合| 亚洲国产欧美网| 在线天堂中文资源库| svipshipincom国产片| 久久久国产欧美日韩av| 国产成人免费观看mmmm| 91成人精品电影| 亚洲国产av新网站| 亚洲少妇的诱惑av| 在线av久久热| 午夜免费成人在线视频| 桃花免费在线播放| 999久久久国产精品视频| 久久九九热精品免费| 老司机在亚洲福利影院| 亚洲av欧美aⅴ国产| 五月天丁香电影| 男女之事视频高清在线观看| 高清欧美精品videossex| 99国产综合亚洲精品| 黑人操中国人逼视频| 在线观看一区二区三区激情| 十分钟在线观看高清视频www| 好男人电影高清在线观看| 亚洲人成电影免费在线| 三上悠亚av全集在线观看| 69精品国产乱码久久久| 亚洲全国av大片| 亚洲人成电影免费在线| 自线自在国产av| 后天国语完整版免费观看| 黄网站色视频无遮挡免费观看| 一边摸一边抽搐一进一小说 | 午夜两性在线视频| 丝袜美腿诱惑在线| 国产免费视频播放在线视频| 午夜福利在线免费观看网站| 正在播放国产对白刺激| 亚洲国产毛片av蜜桃av| 女人精品久久久久毛片| 日韩成人在线观看一区二区三区| 人妻久久中文字幕网| 日本五十路高清| a级毛片在线看网站| 亚洲欧美一区二区三区久久| 国产精品.久久久| 久久国产亚洲av麻豆专区| av有码第一页| 在线观看舔阴道视频| 91成年电影在线观看| 午夜日韩欧美国产| 成在线人永久免费视频| 午夜福利影视在线免费观看| 满18在线观看网站| 黄色视频在线播放观看不卡| 99riav亚洲国产免费| 侵犯人妻中文字幕一二三四区| 亚洲国产欧美一区二区综合| 亚洲中文字幕日韩| 久久香蕉激情| 人人妻,人人澡人人爽秒播| 热99re8久久精品国产| 亚洲全国av大片| 一区二区av电影网| 午夜福利视频在线观看免费| 2018国产大陆天天弄谢| 1024香蕉在线观看| 久久99热这里只频精品6学生| 啦啦啦 在线观看视频| 久久 成人 亚洲| 美女高潮到喷水免费观看| 男男h啪啪无遮挡| 天天添夜夜摸| 在线 av 中文字幕| 中亚洲国语对白在线视频| 久热爱精品视频在线9| 中亚洲国语对白在线视频| 黑人巨大精品欧美一区二区mp4| 超色免费av| 国产一区二区三区视频了| 久久午夜亚洲精品久久| 嫩草影视91久久| 免费不卡黄色视频| 午夜福利欧美成人| 欧美大码av| 欧美黄色片欧美黄色片| 国产免费视频播放在线视频| 91av网站免费观看| 国产精品99久久99久久久不卡| 国产黄色免费在线视频| 悠悠久久av| 国产成人av教育| 国产男靠女视频免费网站| 少妇的丰满在线观看| 精品视频人人做人人爽| 丰满迷人的少妇在线观看| 99国产精品免费福利视频| 久久99热这里只频精品6学生| 久久亚洲真实| 动漫黄色视频在线观看| 无人区码免费观看不卡 | 国产片内射在线| 1024香蕉在线观看| 丁香六月欧美| 免费女性裸体啪啪无遮挡网站| 美女国产高潮福利片在线看| 亚洲人成电影观看| 免费在线观看影片大全网站| 亚洲国产av影院在线观看| 丝袜喷水一区| 色尼玛亚洲综合影院| 少妇被粗大的猛进出69影院| 精品少妇久久久久久888优播| 亚洲av日韩精品久久久久久密| 91九色精品人成在线观看| 亚洲av日韩在线播放| 在线观看66精品国产| 如日韩欧美国产精品一区二区三区| 狠狠精品人妻久久久久久综合| 两人在一起打扑克的视频| 精品一区二区三卡| 黑人欧美特级aaaaaa片| 午夜福利免费观看在线| 国产精品国产高清国产av | 久久人人爽av亚洲精品天堂| 一进一出好大好爽视频| 2018国产大陆天天弄谢| 99精品欧美一区二区三区四区| 真人做人爱边吃奶动态| 亚洲国产精品一区二区三区在线| 欧美成人午夜精品| 国产国语露脸激情在线看| 免费看a级黄色片| 欧美另类亚洲清纯唯美| 午夜福利,免费看| 少妇猛男粗大的猛烈进出视频| 中文字幕人妻丝袜制服| 在线观看免费视频日本深夜| 国产国语露脸激情在线看| 一个人免费看片子| 久久久久精品国产欧美久久久| 久久久久精品人妻al黑| 夜夜骑夜夜射夜夜干| 一级,二级,三级黄色视频| 999久久久精品免费观看国产| 无人区码免费观看不卡 | 50天的宝宝边吃奶边哭怎么回事| 精品久久久久久久毛片微露脸| 五月天丁香电影| 黄片大片在线免费观看| 久久精品国产a三级三级三级| 一级片'在线观看视频| 国产91精品成人一区二区三区 | 满18在线观看网站| 热re99久久精品国产66热6| 精品一区二区三区四区五区乱码| 精品一品国产午夜福利视频| 脱女人内裤的视频| 久久人妻熟女aⅴ| 侵犯人妻中文字幕一二三四区| 中文字幕人妻熟女乱码| 巨乳人妻的诱惑在线观看| 成人18禁高潮啪啪吃奶动态图| 日韩熟女老妇一区二区性免费视频| 亚洲va日本ⅴa欧美va伊人久久| 国产黄色免费在线视频| 黑人巨大精品欧美一区二区蜜桃| 亚洲国产中文字幕在线视频| 日韩三级视频一区二区三区| 高清欧美精品videossex| 久久久久国内视频| 大型黄色视频在线免费观看| 熟女少妇亚洲综合色aaa.| 亚洲久久久国产精品| 精品卡一卡二卡四卡免费| 精品福利永久在线观看| 国产高清视频在线播放一区| 欧美成人免费av一区二区三区 | 亚洲九九香蕉| 日韩一区二区三区影片| 日本撒尿小便嘘嘘汇集6| 久久精品熟女亚洲av麻豆精品| 高潮久久久久久久久久久不卡| 国产有黄有色有爽视频| 日韩中文字幕欧美一区二区| 夜夜夜夜夜久久久久| 欧美变态另类bdsm刘玥| 亚洲成人手机| 1024视频免费在线观看| 欧美+亚洲+日韩+国产| 国产男女内射视频| 国产精品九九99| 色老头精品视频在线观看| 国产欧美日韩一区二区精品| 亚洲第一av免费看| 青青草视频在线视频观看| 香蕉丝袜av| 黑人巨大精品欧美一区二区mp4| 一区二区av电影网| 国产精品久久久人人做人人爽| 人人澡人人妻人| 黄色视频,在线免费观看| 一级黄色大片毛片| 日本vs欧美在线观看视频| 热99久久久久精品小说推荐| 美女福利国产在线| 亚洲国产欧美一区二区综合| 黑人巨大精品欧美一区二区蜜桃| 一级毛片电影观看| 视频区欧美日本亚洲| 激情在线观看视频在线高清 | 午夜福利视频精品| 亚洲精华国产精华精| 韩国精品一区二区三区| 伦理电影免费视频| 俄罗斯特黄特色一大片| 激情视频va一区二区三区| 两人在一起打扑克的视频| 宅男免费午夜| 高清欧美精品videossex| 欧美成狂野欧美在线观看| 亚洲欧美色中文字幕在线| 国产精品一区二区免费欧美| 精品免费久久久久久久清纯 | 女性生殖器流出的白浆| 一二三四在线观看免费中文在| 国产精品秋霞免费鲁丝片| 久热这里只有精品99| 丝袜美足系列| 1024视频免费在线观看| 国产日韩欧美亚洲二区| 最新美女视频免费是黄的| 久久中文字幕一级| 999久久久精品免费观看国产| 亚洲第一欧美日韩一区二区三区 | 正在播放国产对白刺激| 99国产综合亚洲精品| 精品国产超薄肉色丝袜足j| 亚洲第一欧美日韩一区二区三区 | 国产aⅴ精品一区二区三区波| 日韩视频一区二区在线观看| 在线观看免费视频日本深夜| 一本色道久久久久久精品综合| 久久av网站| 高清欧美精品videossex| 麻豆国产av国片精品| 午夜福利欧美成人| 91精品国产国语对白视频| 久久亚洲真实| 女人高潮潮喷娇喘18禁视频| 青青草视频在线视频观看| 久久99一区二区三区| 亚洲全国av大片| 国产人伦9x9x在线观看| 免费观看av网站的网址| 午夜视频精品福利| 丰满人妻熟妇乱又伦精品不卡| 俄罗斯特黄特色一大片| 欧美亚洲日本最大视频资源| 一级片'在线观看视频| 视频区欧美日本亚洲| 国产日韩欧美视频二区| 成年女人毛片免费观看观看9 | 高清黄色对白视频在线免费看| 18禁观看日本| 制服人妻中文乱码| 99精国产麻豆久久婷婷| 婷婷成人精品国产| 熟女少妇亚洲综合色aaa.| 亚洲人成77777在线视频| 亚洲欧美激情在线| 亚洲精品乱久久久久久| 男女床上黄色一级片免费看| www日本在线高清视频| 无人区码免费观看不卡 | 亚洲午夜理论影院| 成年人黄色毛片网站| 午夜福利欧美成人| 王馨瑶露胸无遮挡在线观看| 这个男人来自地球电影免费观看| 亚洲成人免费av在线播放| 人人澡人人妻人| 国产av精品麻豆| 久久婷婷成人综合色麻豆| 一级毛片电影观看| 免费观看av网站的网址| 91字幕亚洲| 久久午夜综合久久蜜桃| 国产成人精品久久二区二区91| 亚洲伊人色综图| 精品少妇久久久久久888优播| 最近最新免费中文字幕在线| 天天躁狠狠躁夜夜躁狠狠躁| 91精品国产国语对白视频| 青草久久国产| 久久狼人影院|